Tickers: XTSX:VPT, PINX:VPTDF
Tags: Heathcare, Technology

Toronto, Ontario / TheNewswire / April 23, 2018 - Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Company", TSXV:VPT) is pleased to announce that it exhibited at the 20th annual Canadian Society of Echocardiography conference which was recently held in Toronto. The gathering is attended by cardiologists and sonographers, and is the largest single gathering in Canada with over 600 attendees.

This was an opportunity to showcase our latest VMS+ system that demonstrated volumetric measures for all 4 chambers of the heart. This new system was well received by clinicians who appreciated the value of ultrasound 3D visualization with fast and accurate measurements, equivalent to the gold standard MRI for all heart chambers. High profile cardiologists from all the main cardiac centers in Canada visited the booth and expressed interest in this unique product. This gave us the opportunity to engage with potential customers and to collect prospects and leads to contribute to our expanding sales effort.

"Attending trade shows and conferences of this nature is part of ramping up our marketing efforts to create further awareness and contacts to drive future sales," noted Desmond Hirson, President of Ventripoint. The next major conference we will be exhibiting at is the American Society of Echocardiology's 29th Annual Scientific Sessions, June 22-26, in Nashville, TN, which attracts over 1,800 attendees.

About Ventripoint Diagnostics Ltd.

Ventripoint's technology is a leading Artificial Intelligence (AI) approach known as Knowledge-Based Reconstruction (KBR), used to create applications to monitor heart disease, a leading cause of death worldwide. The VMS+ is the first cost-effective and accurate AI tool for measuring whole heart function using conventional ultrasound. The Company has developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac care.

For further information please contact:

Dr. George Adams, CEO, Telephone: (519) 803-6937

Email: gadams@ventripoint.com

Forward Looking Statements:

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward-looking information or statements. The forward-looking statements and information are based on certain key expectations and assumptions made by the Corporation. Although the Corporation believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Corporation can give no assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Other factors, which could materially affect such forward-looking information are described in the risk factors in the Corporation's most recent annual management's discussion and analysis that is available on the Corporation's profile on SEDAR at www.sedar.com. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward-looking statements included in this news release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this news release are made as of the date hereof and the Corporation undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2018 TheNewswire - All rights reserved.